Literature DB >> 12754336

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles.

A Riazi1, J C Hobart, D L Lamping, R Fitzpatrick, J A Freeman, C Jenkinson, V Peto, A J Thompson.   

Abstract

OBJECTIVE: To examine the relative impact of two chronic neurological disorders, multiple sclerosis and Parkinson's disease, by comparing patients' scores on the medical outcomes study 36-item short form health survey (SF-36) with the health profile of the United Kingdom population norms.
METHODS: 638 people representing the full spectrum of multiple sclerosis and 227 patients with Parkinson's disease were studied. Health status was measured by the SF-36. Scores for the eight health domains were compared after controlling for age, sex, disease duration, mobility, social class, ethnicity, education, marital status, and employment status.
RESULTS: People with multiple sclerosis and those with Parkinson's disease had significantly worse health than the general population on all eight domains measured by the SF-36. The relative impact of multiple sclerosis and Parkinson's disease were similar, but multiple sclerosis resulted in poorer scores on physical functioning and better scores in mental health. People with mild multiple sclerosis who walked without an aid also had significantly worse scores in all dimensions than the general UK population.
CONCLUSIONS: The results highlight the need for further research into aspects of health measured by the SF-36. Nevertheless, generic measures that are applicable across multiple diseases may fail to address clinically important aspects of the impact of specific disorders.

Entities:  

Mesh:

Year:  2003        PMID: 12754336      PMCID: PMC1738466          DOI: 10.1136/jnnp.74.6.710

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus Survey in Britain, the Health Survey for England and the Oxford Healthy Life Survey.

Authors:  A Bowling; M Bond; C Jenkinson; D L Lamping
Journal:  J Public Health Med       Date:  1999-09

2.  Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population.

Authors:  M W Nortvedt; T Riise; K M Myhr; H I Nyland
Journal:  Med Care       Date:  2000-10       Impact factor: 2.983

3.  Health status and quality of life of people with multiple sclerosis.

Authors:  H L Ford; E Gerry; M H Johnson; A Tennant
Journal:  Disabil Rehabil       Date:  2001-08-15       Impact factor: 3.033

4.  How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population.

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  Mov Disord       Date:  2000-11       Impact factor: 10.338

5.  Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39)

Authors:  C Jenkinson; V Peto; R Fitzpatrick; R Greenhall; N Hyman
Journal:  Age Ageing       Date:  1995-11       Impact factor: 10.668

6.  Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression.

Authors:  A Feinstein; K Feinstein
Journal:  J Affect Disord       Date:  2001-10       Impact factor: 4.839

7.  Which chronic conditions are associated with better or poorer quality of life?

Authors:  M A Sprangers; E B de Regt; F Andries; H M van Agt; R V Bijl; J B de Boer; M Foets; N Hoeymans; A E Jacobs; G I Kempen; H S Miedema; M A Tijhuis; H C de Haes
Journal:  J Clin Epidemiol       Date:  2000-09       Impact factor: 6.437

8.  Diagnostic criteria for primary progressive multiple sclerosis: a position paper.

Authors:  A J Thompson; X Montalban; F Barkhof; B Brochet; M Filippi; D H Miller; C H Polman; V L Stevenson; W I McDonald
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

9.  Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis.

Authors:  J A Freeman; J C Hobart; D W Langdon; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

10.  The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.

Authors:  J Hobart; D Lamping; R Fitzpatrick; A Riazi; A Thompson
Journal:  Brain       Date:  2001-05       Impact factor: 13.501

View more
  41 in total

1.  Psychometric properties of the patient activation measure among multimorbid older adults.

Authors:  Richard L Skolasky; Ariel Frank Green; Daniel Scharfstein; Chad Boult; Lisa Reider; Stephen T Wegener
Journal:  Health Serv Res       Date:  2010-11-19       Impact factor: 3.402

2.  Risk of sleep-disordered breathing in Parkinson's disease.

Authors:  Wattanachai Chotinaiwattarakul; Praveen Dayalu; Ronald D Chervin; Roger L Albin
Journal:  Sleep Breath       Date:  2010-05-16       Impact factor: 2.816

3.  Psychometric properties of measures of upper limb activity performance in adults with and without spasticity undergoing neurorehabilitation-A systematic review.

Authors:  Shannon Pike; Anne Cusick; Kylie Wales; Lisa Cameron; Lynne Turner-Stokes; Stephen Ashford; Natasha A Lannin
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

4.  Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis.

Authors:  Tatiana Dubayova; Martina Krokavcova; Iveta Nagyova; Jaroslav Rosenberger; Zuzana Gdovinova; Berrie Middel; Johan W Groothoff; Jitse P van Dijk
Journal:  Qual Life Res       Date:  2012-10-11       Impact factor: 4.147

5.  Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners.

Authors:  Nicholas G Larocca
Journal:  Patient       Date:  2011       Impact factor: 3.883

Review 6.  The effect of deep brain stimulation on quality of life in movement disorders.

Authors:  A Diamond; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

7.  Clinical features of spinal and bulbar muscular atrophy.

Authors:  Lindsay E Rhodes; Brandi K Freeman; Sungyoung Auh; Angela D Kokkinis; Alison La Pean; Cheunju Chen; Tanya J Lehky; Joseph A Shrader; Ellen W Levy; Michael Harris-Love; Nicholas A Di Prospero; Kenneth H Fischbeck
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

Review 8.  Health-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatment.

Authors:  Richard A Rudick; Deborah M Miller
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  The Burden of Stroke Scale (BOSS) provided valid, reliable, and responsive score estimates of functioning and well-being during the first year of recovery from stroke.

Authors:  Patrick J Doyle; Malcolm R McNeil; James E Bost; Katherine B Ross; Julie L Wambaugh; William D Hula; Joseph M Mikolic
Journal:  Qual Life Res       Date:  2007-07-31       Impact factor: 4.147

10.  SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures.

Authors:  Carlos A Brown; Eric M Cheng; Ron D Hays; Stefanie D Vassar; Barbara G Vickrey
Journal:  Qual Life Res       Date:  2009-08-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.